NAC1 modulates autoimmunity by suppressing regulatory T cell-mediated tolerance

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Regulatory T cells (Tregs) are crucial for maintaining immune tolerance.
• FoxP3 is a key transcription factor regulating Treg function.
• The role of nucleus accumbens-associated protein-1 (NAC1) in immune regulation is not fully understood.

Purpose of the Study:

• To investigate the role of NAC1 as a regulator of FoxP3 in Tregs.
• To determine the impact of NAC1 on immune tolerance and autoimmunity.
• To explore NAC1 as a potential therapeutic target for autoimmune diseases.

Main Methods:

• Analysis of NAC1 knockout (NAC1-/-) mice.
• Assessment of CD4+ Treg populations, their metabolic profile, and immune-suppressive activity.
• Investigation of FoxP3 acetylation, expression, and turnover.
• Treatment of Tregs with proinflammatory cytokines (IL-1β, TNF-α) and analysis of NAC1 and FoxP3 levels.

Main Results:

• NAC1 deficiency in mice led to increased immune tolerance and a higher number of CD4+ Tregs.
• NAC1-/- Tregs exhibited enhanced metabolic fitness, immune-suppressive activity, increased FoxP3 acetylation and expression, and slower turnover.
• Proinflammatory cytokines induced NAC1 upregulation while downregulating FoxP3 and acetylated FoxP3 in Tregs.

Conclusions:

• NAC1 acts as a negative regulator of FoxP3 in Tregs, destabilizing them and suppressing immune tolerance.
• NAC1 functions as a trigger for immune responses by impairing Treg-mediated tolerance.
• Targeting NAC1 presents a promising strategy for developing novel tolerogenic therapies for autoimmune disorders.